Delivery Order SPE2DB22D2108-SPE2DB24FU4YE

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,682.10 firm fixed price delivery order is for the supply of Diclofenac Sodium 1% Gel, a pain management medication, with a completion date of June 24, 2025. The contract is not set aside and is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred forty-one thousand six hundred sixty dollars to Amerisourcebergen Drug Corporation for Diclofenac Sodium 1% Gel 100gm. The single day contract has a period of performance from August 7 through August 8, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for a topical nonsteroidal...
<p>The Defense Logistics Agency awarded a $274,560 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Diclofenac Sodium 1% Gel 100gm. The prime contractor will deliver the topical pain reliever to a facility in Conshohocken, Pennsylvania by July 26, 2023 in support of the Defense Logistics Agency's medical supply procurement programs. No subcontractors or set aside designations were identified in the award information.</p>
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The order is for the supply of Voltaren Arthritis Pain 1% Gel, a prescription topical pain medication, valued at $1,261.49. The contract has a period of performance through September 19, 2024 and is a firm fixed-price type. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award, SPE2DB20D1004|SPE2DB25FNGQJ, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568037981 - DICLOFENAC-MISOPROST 50-0.2 MG 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,109.05 and an ultimate completion date of April 28, 2025. The contract is not set aside and was open...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $57,324.19, is for the supply of Diclofenac Potassium 50 mg powder packets. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and medical supplies to support DLA programs. This delivery order is not associated with a set-aside designation....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,202,194 dicloxacillin 250 mg capsules. The $1,464.17 firm fixed-price contract has an ultimate completion date of October 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Diclofenac Potassium 50 mg powder packets, with a ceiling value of $1,502.36 and a period of performance through June 17, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at thirty-three dollars and thirty-six cents to Amerisourcebergen Drug Corporation for one hundred tablets of the generic pharmaceutical diclofenac potassium. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its place of performance in Conshohocken, Pennsylvania by June 23, 2023. The delivery order was placed under an existing DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the U.S. government. The $8,818.00 firm fixed price delivery order is for the supply of GEL-ONE 30 MG/3 ML syringes, a medical product used for the treatment of osteoarthritis. The contract has an ultimate completion date of September 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB24FU4YE
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,858.98 firm fixed-price contract is for 4565891088 - Diclofenac Sodium 3% Gel 100GM, a topical anti-inflammatory medication. The delivery order has an ultimate completion date of September 23, 2024 and does not have a set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through December 2025 for delivering a wide range of medical commodities to support military treatment programs and facilities worldwide. This specific delivery order is likely part of that larger IDC vehicle, which enables the DLA to efficiently procure essential pharmaceutical products from Amerisourcebergen to meet the healthcare needs of the U.S. military and other federal beneficiaries.

Generated 12/20/24, 9:33 AM